TP53 and neoplasm: The invasive and aggressive indexes of PLA1A were compared by immunohistochemistry, with the invasive panel including Ki-67+, S-100+, P53+, HMB-45+, and Melena+ index evaluated in tumor sections (Fig. 1C).